igfbp3 / tmem219 axis inhibitor, pharmaceutical composition for use in the treatment and / or prevention of diabetes, method for identifying an individual at risk for developing type 1 and / or type 2 diabetes or for monitoring the response to therapeutic treatment in an individual and kit

摘要

The present invention relates to the function of the igfbp3 / tmem219 axis in the onset of diabetes and the related use of the igfbp3 / tmem219 axis inhibitors for the treatment and / or prevention of diabetes. The invention also relates to a method for identifying an individual at risk of developing type 1 and / or type 2 diabetes and related kit.